Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell Lines-Reference-Cited by-同舟云学术

Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell Lines

Published:2011-04-29 Issue:4 Volume:6 Page:e19322
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boegsted Martin,Holst Johanne M.,Fogd Kirsten,Falgreen Steffen,Sørensen Suzette,Schmitz Alexander,Bukh Anne,Johnsen Hans E.,Nyegaard Mette,Dybkaer Karen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference41 articles.

1. High-dose intravenous melphalan: a review.;BL Samuels;J Clin Oncol,1995

2. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.;JA Child;N Engl J Med,2003

3. Targeting the Fanconi anemia/BRCA pathway circumvents drug resistance in multiple myeloma.;DN Yarde;Cancer Res,2009

4. A gene expression database for the molecular pharmacology of cancer.;U Scherf;Nat Genet,2000

5. Microarrays: retracing steps.;KR Coombes;Nat Med,2007

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of comparative transcriptomic studies of cellular resistance to genotoxic stress;Mutation Research/Reviews in Mutation Research;2023-07

2. An integrated prognosis model of pharmacogenomic gene signature and clinical information for diffuse large B-cell lymphoma patients following CHOP-like chemotherapy;Journal of Translational Medicine;2020-03-30

3. A bendamustine resistance gene signature in diffuse large B-cell lymphoma and multiple myeloma;Cancer Drug Resistance;2020

4. Therapeutic Targets and Signaling Pathways for Diagnosis of Myeloma;Update on Multiple Myeloma;2019-02-20

5. A multiple myeloma classification system that associates normal B-cell subset phenotypes with prognosis;Blood Advances;2018-09-25